|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||($121)||Benefits minus costs||($2,574)|
|Participants||($206)||Benefit to cost ratio||($1.75)|
|Others||$122||Chance the program will produce|
|Indirect||($1,433)||benefits greater than the costs||47 %|
|Net program cost||($937)|
|Benefits minus cost||($2,574)|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Any criminal conviction according to court records, sometimes measured through charges, arrests, incarceration, or self-report.
Illicit drug use disorder
Clinical diagnosis of illicit drug use disorder or symptoms measured on a validated scale. When possible, we exclude cannabis/marijuana use disorder from this outcome.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Crime||Criminal justice system||$179||$0||$355||$89||$623|
|Illicit drug use disorder||Labor market earnings associated with illicit drug abuse or dependence||($58)||($136)||$0||$0||($193)|
|Health care associated with illicit drug abuse or dependence||($226)||($35)||($233)||($113)||($607)|
|Mortality associated with illicit drugs||($15)||($35)||$0||($940)||($991)|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($468)||($468)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$889||2016||Present value of net program costs (in 2018 dollars)||($937)|
|Comparison costs||$0||2016||Cost range (+ or -)||10 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
California Department of Corrections. (1997). Los Angeles Prison Parole Network: An evaluation report. CA: Author.
Grommon, E., Davidson, I.I. W.S., & Bynum, T.S. (2013). A randomized trial of a multimodal community-based prisoner reentry program emphasizing substance abuse treatment. Journal of Offender Rehabilitation, 52(4), 287-309.
Krebs, C.P., Strom, K.J., Koetse, W.H., & Lattimore, P.K. (2009). The impact of residential and nonresidential drug treatment on recidivism among drug-involved probationers: A survival analysis. Crime and Delinquency, 55(3), 442-471.
Martin, S.S., & Scarpitti, F.R. (1993). An intensive case management approach for paroled iv drug users. Journal of Drug Issues, 23(1), 43-59.
Zanis, D., Mulvaney, F., Coviello, D., Alterman, A., Savitz, B., & Thompson, W. (2003). The effectiveness of early parole to substance abuse treatment facilities on 24-month criminal recidivism. Journal of Drug Issues, 33(1), 223-235.